
Sanjay Basu on affordable T2D medicine in LMICs
Sanjay Basu talks with The Lancet Diabetes & Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00240-0/fulltext
Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Diabetes & Endocrinology in conversation with... is part of the Lancet Group podcast offering.
Editorial team: Marta Koch, David Holmes, and Susan Rahimi
Podcast editing and production: Matteo Simonetti
Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.
Find the best science for better lives at https://www.thelancet.com/journals/landia/home Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
D'autres épisodes de "The Lancet Diabetes & Endocrinology in conversation with"



Ne ratez aucun épisode de “The Lancet Diabetes & Endocrinology in conversation with” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.








